Construction of chimeric antigen receptor‑modified T cells targeting EpCAM and assessment of their anti‑tumor effect on cancer cellsYan Zhou(Nanchang University), Xiao‐An Li(First Affiliated Hospital of Chengdu Medical College)Molecular Medicine ReportsJuly 3, 201910.3892/mmr.2019.10460Cited by 20SaveCiteExport RISWatch citationsRelated PapersLoss of Perp in T Cells Promotes Resistance to Apoptosis of T Helper 17 Cells and Exacerbates the Development of Experimental Autoimmune Encephalomyelitis in Mice|Frontiers in Immunology|2018|8